| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/12/2001 | EP1131449A1 Method for identifying inhibitors of ipc synthase |
| 09/12/2001 | EP1131445A1 Human phospholipases |
| 09/12/2001 | EP1131440A2 Process for oxidising terpenes |
| 09/12/2001 | EP1131428A2 Immunoglobulin superfamily proteins |
| 09/12/2001 | EP1131417A2 Engineered cytotoxic ribonuclease |
| 09/12/2001 | EP1131414A1 Stable, attenuated rabies virus mutants and live vaccines thereof |
| 09/12/2001 | EP1131408A2 Cells, culture methods, and their use in autologous transplantation therapy |
| 09/12/2001 | EP1131358A1 Humanized antibody specific for surface antigen pre-s1 of hbv and preparation method thereof |
| 09/12/2001 | EP1131356A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies |
| 09/12/2001 | EP1131352A2 Rantes-derived peptides with anti-hiv activity |
| 09/12/2001 | EP1131348A1 Regulatory/unfolding peptides of ezrin |
| 09/12/2001 | EP1131346A1 Heliobacter pylori antigen |
| 09/12/2001 | EP1131340A2 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
| 09/12/2001 | EP1131334A1 Use of core 2 glcnac transferase inhibitors in treating inflammation |
| 09/12/2001 | EP1131331A1 13-membered azalides and their use as antibiotic agents |
| 09/12/2001 | EP1131315A1 Polyhydroxylated heterocyclic derivatives as anti-coagulants |
| 09/12/2001 | EP1131314A1 Compounds having cytokine inhibitory activity |
| 09/12/2001 | EP1131303A1 Crystalline (-)-6- chloro-4- cyclopropylethynyl- 4-trifluoromethyl- 3,4-dihydro- 2(1h)-quinazolinone |
| 09/12/2001 | EP1131301A1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
| 09/12/2001 | EP1131291A1 4-aroyl-piperidin-ccr-3 receptor antagonists iii |
| 09/12/2001 | EP1131290A1 Piperidine ccr-3 receptor antagonists |
| 09/12/2001 | EP1131104A1 Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester |
| 09/12/2001 | EP1131094A1 Multivalent t.d. polio vaccine against at least diphtheria, poliomyelitis and tetanus |
| 09/12/2001 | EP1131092A1 Intradermal avian immunization with inactivated vaccines |
| 09/12/2001 | EP1131091A1 Method of treating viral hemorrhagic fever |
| 09/12/2001 | EP1131084A1 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists |
| 09/12/2001 | EP1131075A2 Use of phosphonoformic acid derivatives for treating infections |
| 09/12/2001 | EP1131039A2 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 09/12/2001 | EP1131037A1 Process for the manufacture of liquid filled capsules |
| 09/12/2001 | EP1130969A1 Murf2 polypeptides and polynucleotides |
| 09/12/2001 | EP1130964A1 Therapeutic anti-fungal nail preparation |
| 09/12/2001 | EP1049481A4 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same |
| 09/12/2001 | EP0915845B1 Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| 09/12/2001 | EP0843680B1 Process for the preparation of potassium clavulanate |
| 09/12/2001 | EP0839206B1 Cd4 gene regulatory sequences specifically expressed in mature t cells |
| 09/12/2001 | EP0808326B1 Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics |
| 09/12/2001 | EP0666751B1 Mutants of hepatitis a virus strain hm-175 for use as hepatitis a vaccines |
| 09/12/2001 | EP0629203B1 Desosamino derivatives of macrolides as immunosuppressants and antifungal agents |
| 09/12/2001 | EP0621898B1 Chimeric immunogens |
| 09/12/2001 | EP0586474B1 Peptide nucleic acids |
| 09/12/2001 | EP0449856B1 Pneumolysin mutants and pneumococcal vaccines made therefrom |
| 09/12/2001 | CN1312858A Bactericidal/permeability-increasing protein delation analogs |
| 09/12/2001 | CN1312856A Enzymatic nucleic acid treamtent of diseases or conditions related to hepatitisc virus infection |
| 09/12/2001 | CN1312810A Substituted 1,8-naphthyridin-4(1H)-ones as phosphodiesterase 4 inhibitors |
| 09/12/2001 | CN1312725A Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 09/12/2001 | CN1312723A Compound and method for diagnosis of tuberculosis |
| 09/12/2001 | CN1312722A Compounds obtained from i(salvia) species having antiviral activity |
| 09/12/2001 | CN1312719A Pharmaceutical Composition |
| 09/12/2001 | CN1312293A Gene antibiotic peptide medicine prepared from transgenic antibiotic peptide fly maggot and its use |
| 09/12/2001 | CN1312254A Novel nucleoside |
| 09/12/2001 | CN1312150A Process for high polymer synthesis to phenol compounds and the like and use thereof |
| 09/12/2001 | CN1312112A Cure-all ointment |
| 09/12/2001 | CN1312110A Chinese medicine preparation for treating infant pulmonitis and dyspneic cough |
| 09/12/2001 | CN1312077A Composite component comprising the effective extracts of licorice and lightyellow sophora and its application |
| 09/12/2001 | CN1312065A Use of compound for improving skin and its mucous membrane physical-chemical property to prevent adsorption of microorganism |
| 09/12/2001 | CN1070707C Chinese medicinal preparation for treating Aids and its preparing method thereof |
| 09/11/2001 | US6288234 Fluorinated heterocyclic amido amine compounds as drugs |
| 09/11/2001 | US6288218 Detecting gene expression in sample; incubate nucleotide sequences and primers, allow hybridization and detect hybridization products |
| 09/11/2001 | US6288084 Administering comounds such as 4-(4-chlorophenyl)-1-(4-(3-methoxyphenyl)-4-(3-pyridinyl)-3 -butenyl)piperidin-4-ol to treat diseases associated with aberrant leukocyte recruitment and/or activation |
| 09/11/2001 | US6288083 Chemokine receptor antagonists and methods of use therefor |
| 09/11/2001 | US6288081 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating Helicobacter pylori infections and the gastroduodenal diseases associated therewith |
| 09/11/2001 | US6288069 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| 09/11/2001 | US6288062 Interleukin and tumor necrosis factor inhibitors; antiinflammatory agents; rheumatic diseases; antiarthritic agents; respiratory system disorders |
| 09/11/2001 | US6288054 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 09/11/2001 | US6288044 O-sulfated bacterial polysaccharides |
| 09/11/2001 | US6288033 Treatment of hepatitis B infection with thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir |
| 09/11/2001 | US6287856 Beak and feather disease nucleic acids; genetically engineered proteins made from open reading frame vectors; veterinary medicine |
| 09/11/2001 | US6287853 Genetically engineered escherichia plasmid; marking antibiotic resistance; artificial chromosomes; genetic mapping |
| 09/11/2001 | US6287836 Histidine kinase from Streptococcus pneumoniae and compositions therecontaining |
| 09/11/2001 | US6287827 Fermentation of nocardia; administered to treat drug or antibiotic resistant grampositive bacterial infections |
| 09/11/2001 | US6287811 Biologically active bactericidal/permeability-increasing protein fragments |
| 09/11/2001 | US6287804 nrdG |
| 09/11/2001 | US6287803 Polynucleotides encoding a novel era polypeptide |
| 09/11/2001 | US6287759 Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 09/11/2001 | US6287594 Oral liquid compositions |
| 09/11/2001 | US6287585 Microbiocides |
| 09/11/2001 | US6287575 Vaccine against papillomatous digital dermatitis (PDD) |
| 09/11/2001 | US6287574 Proteinase K resistant surface protein of neisseria meningitidis |
| 09/11/2001 | US6287573 Injectable vaccine |
| 09/11/2001 | US6287572 Genetic engineering |
| 09/11/2001 | US6287571 Replication-defective adenovirus human type 5 recombinant as a vaccine carrier |
| 09/11/2001 | US6287570 Purified dna |
| 09/11/2001 | US6287566 Isolated polypeptide |
| 09/11/2001 | US6287565 Modified HGP-30 heteroconjugates, compositions and methods of use |
| 09/11/2001 | US6287561 Pathogen-targeted biocatalysts |
| 09/11/2001 | US6287554 Chicken interleukin-15 and uses thereof |
| 09/11/2001 | CA2166889C Oligonucleotides with activity against human immunodeficiency virus |
| 09/07/2001 | WO2001064943A1 Method of screening substance specifically inhibiting non-mevalonate pathway |
| 09/07/2001 | WO2001064907A2 Lipid metabolism enzymes |
| 09/07/2001 | WO2001064884A2 G12l, a gene associated with the thermal response |
| 09/07/2001 | WO2001064879A2 G-proteins coupled receptor related polypeptides |
| 09/07/2001 | WO2001064860A2 Recombinant influenza a viruses |
| 09/07/2001 | WO2001064755A2 Isoxazole gegen virale erkrankungen |
| 09/07/2001 | WO2001064752A2 Antibody inhibiting the binding between gp120 and dc-sign and screening methods |
| 09/07/2001 | WO2001064751A2 High potency recombinant antibodies and method for producing them |
| 09/07/2001 | WO2001064749A2 Method for preparing anti-mif antibodies |
| 09/07/2001 | WO2001064738A2 Heparin-binding amino acid sequences derived from human proteins facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/07/2001 | WO2001064716A1 Antiviral compounds |
| 09/07/2001 | WO2001064700A1 Novel macrolide compound jk |
| 09/07/2001 | WO2001064693A1 Phosphonate nucleotide compound |